Skip to Content

D R (Lamivudine and Zidovudine 150 mg / 300 mg)

Pill with imprint D R is White, Capsule-shape and has been identified as Lamivudine and Zidovudine 150 mg / 300 mg. It is supplied by Cipla USA Inc..

Lamivudine/zidovudine is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for D R

Lamivudine and Zidovudine

Imprint
D R
Strength
150 mg / 300 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0315

Get help with Imprint Code FAQs.

Related Images for "D R"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.